ARTIX
Price
$35.18
Change
-$0.22 (-0.62%)
Updated
Oct 17 closing price
Net Assets
6.13B
RERAX
Price
$60.79
Change
-$0.26 (-0.43%)
Updated
Oct 17 closing price
Net Assets
137.06B
Interact to see
Advertisement

ARTIX vs RERAX

Header iconARTIX vs RERAX Comparison
Open Charts ARTIX vs RERAXBanner chart's image
Artisan International Investor
Price$35.18
Change-$0.22 (-0.62%)
VolumeN/A
Net Assets6.13B
American Funds EUPAC R1
Price$60.79
Change-$0.26 (-0.43%)
VolumeN/A
Net Assets137.06B
ARTIX vs RERAX Comparison Chart in %
View a ticker or compare two or three
VS
ARTIX vs. RERAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTIX is a Hold and RERAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 137B vs. ARTIX (6.13B). ARTIX pays higher dividends than RERAX: ARTIX (0.61) vs RERAX (0.22). ARTIX was incepted earlier than RERAX: ARTIX (30 years) vs RERAX (23 years). RERAX (1.57) is less costly to investors than ARTIX (1.20). ARTIX is a more actively managed with annual turnover of: 83.27 vs. RERAX (35.00). RERAX has a lower initial minimum investment than ARTIX: RERAX (250) vs ARTIX (1000). ARTIX annual gain was more profitable for investors over the last year : 14.78 vs. RERAX (9.84). ARTIX (9.81) and RERAX (9.42) have equivalent 5 years return.
ARTIXRERAXARTIX / RERAX
Total Expense Ratio1.201.5776%
Annual Report Gross Expense Ratio1.201.5776%
Fund Existence30 years23 years-
Gain YTD30.39320.543148%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets6.13B137B4%
Annual Yield % from dividends0.610.22278%
Returns for 1 year14.789.84150%
Returns for 3 years64.6245.45142%
Returns for 5 years9.819.42104%
Returns for 10 years34.6635.4498%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GAP21.600.95
+4.60%
Gap Inc (The)
PCAPU10.55-0.09
-0.80%
Procap Acquisition Corp
BRNS1.33-0.02
-1.33%
Barinthus Biotherapeutics plc
JANX26.76-0.44
-1.62%
Janux Therapeutics
NVEC71.97-1.42
-1.93%
NVE Corp